Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis Patients”

574 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 574 results

Testing effectiveness (Phase 2)Study completedNCT05432596
What this trial is testing

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 250
Early research (Phase 1)Looking for participantsNCT07262983
What this trial is testing

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

Who this might be right for
Hyper IgE Syndrome From STAT3 MutationJob s SyndromeHIES+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableEnded earlyNCT01826630
What this trial is testing

Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema

Who this might be right for
EczemaHand EczemaAtopic Dermatitis
Shari L Hand 4
Large-scale testing (Phase 3)Ended earlyNCT04140695
What this trial is testing

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)

Who this might be right for
Atopic Dermatitis
Vanda Pharmaceuticals 87
Not applicableStudy completedNCT05969730
What this trial is testing

Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Mazandaran University of Medical Sciences 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05509023
What this trial is testing

Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)

Who this might be right for
Atopic Dermatitis
Q32 Bio Inc. 102
Testing effectiveness (Phase 2)Study completedNCT02379910
What this trial is testing

Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AnaMar AB 36
Not applicableStudy completedNCT04772482
What this trial is testing

Study on Hypoallergenic Hair Dye

Who this might be right for
Contact DermatitisAllergy; DermatitisDermatitis
University of Minnesota 8
Testing effectiveness (Phase 2)Study completedNCT02079688
What this trial is testing

Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema

Who this might be right for
Mild to Moderate Atopic Dermatitis
Sterna Biologicals GmbH & Co. KG 25
Post-approval studies (Phase 4)Study completedNCT04016025
What this trial is testing

A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers

Who this might be right for
Adherence, PatientChronic Eczema
Jena University Hospital 80
Post-approval studies (Phase 4)Study completedNCT03667014
What this trial is testing

The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients

Who this might be right for
Atopic DermatitisAtopic Dermatitis Eczema
University of California, San Francisco 34
Not applicableEnded earlyNCT05250115
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 112
Early research (Phase 1)Study completedNCT06553287
What this trial is testing

Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Lynk Pharmaceuticals Co., Ltd 28
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Not applicableStudy completedNCT03327116
What this trial is testing

Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
University of Sao Paulo General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT04162899
What this trial is testing

A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Reistone Biopharma Company Limited 105
Not applicableStudy completedNCT05394792
What this trial is testing

An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 111
Large-scale testing (Phase 3)UnknownNCT03026907
What this trial is testing

Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema

Who this might be right for
Hand Eczema
University Medical Center Groningen 116
Post-approval studies (Phase 4)Ended earlyNCT05200403
What this trial is testing

Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Boston University 72
Not applicableStudy completedNCT01660217
What this trial is testing

Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management

Who this might be right for
Atopic Dermatitis
Dermatology & Aesthetics of Wicker Park 37
Next Page